DARIEN PARHAD

Profile

First Name

: DARIEN

Middle Name

:

Last Name

: PARHAD

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
HARMONY BIOSCIENCES II, INC.
JEFFREY ARONIN, OCTAGON CAPITAL GROUP, LLC, MARTIN EDWARDS, WILBUR GANTZ III, WILBUR GANTZ, III, ANTONIO GRACIAS, JOHN JACOBS, PATRICK MORRIS, JACK NIELSEN, JACK BECH NIELSEN, ROBERT REPELLA, AARON ROYSTON, JUAN SABATER, ANDREW SERAFIN, JOHN VITTORIA, DR. ANDREAS WICKI
EXECUTIVE OFFICER
PARAGON BIOSCIENCES EMALEX CAPITAL, INC.
JEFFREY ARONIN, TIMOTHY CUNNIFF, JEFFREY DAYNO, ANTONIO GRACIAS, ERIC MESSNER, PATRICK MORRIS, PATRICK J. MORRIS, RICKY SUN
EXECUTIVE OFFICER
PARAGON BIOSCIENCES QLARITY CAPITAL, INC.
JEFFREY S. ARONIN, ANTONIO J. GRACIAS, PATRICK J. MORRIS
EXECUTIVE OFFICER
EVOZYNE, LLC
JEFFREY S. ARONIN, MIKE GAMSON, ANTONIO GRACIAS, ALEINA LEE, PATRICK J MORRIS, PATRICK J. MORRIS, ARJUN RALLAPALLI, RAMA RANGANATHAN, MATTHEW RIZZO, JUDE M. SULLIVAN, ARIS THEOLOGIS
EXECUTIVE OFFICER
PARAGON BIOSCIENCES EVOZYNE HOLDINGS, LLC
PATRICK J. MORRIS
EXECUTIVE OFFICER
PARAGON BIOSCIENCES EVOZYNE CAPITAL, LLC
PATRICK J. MORRIS
EXECUTIVE OFFICER
CIRC BIOSCIENCES, INC.
JEFFREY ARONIN, JEFFREY S. ARONIN, SAI CHAVALA, TIMOTHY CUNNIFF, TIMOTHY M. CUNNIFF, ANTONIO GRACIAS, ANTONIO J. GRACIAS, PATRICK MORRIS, PATRICK J MORRIS
EXECUTIVE OFFICER
PARAGON BIOSCIENCES CIRC HOLDINGS, LLC
PATRICK J MORRIS
EXECUTIVE OFFICER
EVOZYNE, INC.
JEFFREY S. ARONIN, MIKE GAMSON, ANTONIO GRACIAS, ALEINA LEE, PATRICK J MORRIS, PATRICK J. MORRIS, ARJUN RALLAPALLI, RAMA RANGANATHAN, MATTHEW RIZZO, JUDE M. SULLIVAN, ARIS THEOLOGIS
EXECUTIVE OFFICER
CASTLE CREEK BIOSCIENCES, INC.
JEFFREY ARONIN, JEFFREY S. ARONIN, DAVID BRILL, MATTHEW CRABTREE, TIMOTHY CUNNIFF, TIMOTHY M. CUNNIFF, MICHAEL DERBY, MATTHEW GANTZ, MATTHEW J. GANTZ, BABAR GHIAS, ANTONIO GRACIAS, ANTONIO J. GRACIAS, MARK GRAF, GREGORY MACMICHAEL, W. BRADFORD MIDDLEKAUFF, PATRICK MORRIS, PATRICK J. MORRIS, MARY SPELLMAN, JUDE SULLIVAN, GREGORY WUJEK
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-07-08
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-18 
2025-03-25
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-18 
2025-02-25
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-02-24 
2024-10-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-02-01 
2024-05-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-04-15 
2023-09-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-09-14 
2022-11-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-21 
2022-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-21 
2022-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-05-18 
2021-04-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-09 
2021-03-12
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-25 
2021-03-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-25 
2020-12-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-23 
2020-12-04
D
Link
OTHER 
 
NOT APPLICABLE 
Equity 
2020-10-23 
2020-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-27 
2020-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-27 
2020-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-27 
2019-11-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-25 
2019-10-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-18 
2018-12-07
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-31 
2018-08-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-31 
2018-01-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-08 
2017-10-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-22